A carregar...

BRCA1/2 testing: therapeutic implications for breast cancer management

Testing for germline BRCA1/2 mutations has an established predictive role in breast cancer risk assessment. More recently, studies have also identified BRCA1/2 status as clinically relevant in the selection of therapy for patients already diagnosed with breast cancer. Emerging breast and ovarian can...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Tung, Nadine M., Garber, Judy E.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6048046/
https://ncbi.nlm.nih.gov/pubmed/29867226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0127-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!